Terms: = Lung cancer AND uPA AND Prognosis
43 results:
1. Effects of thiostrepton alone or in combination with selumetinib on triple-negative breast cancer metastasis.
Demirtas Korkmaz F; Dogan Turacli I; Esendagli G; Ekmekci A
Mol Biol Rep; 2022 Nov; 49(11):10387-10397. PubMed ID: 36097108
[TBL] [Abstract] [Full Text] [Related]
2. The urokinase-type plasminogen activator and inhibitors in resectable lung adenocarcinoma.
Zhu C; Jiang L; Xu J; Ren A; Ju F; Shu Y
Pathol Res Pract; 2020 Apr; 216(4):152885. PubMed ID: 32113794
[TBL] [Abstract] [Full Text] [Related]
3. TIMP3 expression associates with prognosis in colorectal cancer and its novel arylsulfonamide inducer, MPT0B390, inhibits tumor growth, metastasis and angiogenesis.
Huang HL; Liu YM; Sung TY; Huang TC; Cheng YW; Liou JP; Pan SL
Theranostics; 2019; 9(22):6676-6689. PubMed ID: 31588243
[TBL] [Abstract] [Full Text] [Related]
4. MicroRNA-378-3p/5p suppresses the migration and invasiveness of oral squamous carcinoma cells by inhibiting KLK4 expression.
Cui Z; Sun S; Liu Q; Zhou X; Gao S; Peng P; Li Q
Biochem Cell Biol; 2020 Apr; 98(2):154-163. PubMed ID: 31265790
[TBL] [Abstract] [Full Text] [Related]
5. Correlation of Serum Levels of Urokinase Activation Plasminogen (upa) and Its Inhibitor (PAI-1) with Hormonal and HER-2 Status in the Early Invasive Breast cancer.
Pusina S
Med Arch; 2018 Nov; 72(5):335-340. PubMed ID: 30524164
[TBL] [Abstract] [Full Text] [Related]
6. PLOD3 promotes lung metastasis via regulation of STAT3.
Baek JH; Yun HS; Kwon GT; Kim JY; Lee CW; Song JY; Um HD; Kang CM; Park JK; Kim JS; Kim EH; Hwang SG
Cell Death Dis; 2018 Nov; 9(12):1138. PubMed ID: 30442941
[TBL] [Abstract] [Full Text] [Related]
7. Ruscogenin suppressed the hepatocellular carcinoma metastasis via PI3K/Akt/mTOR signaling pathway.
Hua H; Zhu Y; Song YH
Biomed Pharmacother; 2018 May; 101():115-122. PubMed ID: 29477471
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume.
Ostheimer C; Evers C; Bache M; Reese T; Vordermark D
Strahlenther Onkol; 2018 Jun; 194(6):539-551. PubMed ID: 29340706
[TBL] [Abstract] [Full Text] [Related]
9. Urokinase-type plasminogen activator receptor (upaR) expression enhances invasion and metastasis in RAS mutated tumors.
Mauro CD; Pesapane A; Formisano L; Rosa R; D'Amato V; Ciciola P; Servetto A; Marciano R; Orsini RC; Monteleone F; Zambrano N; Fontanini G; Servadio A; Pignataro G; Grumetto L; Lavecchia A; Bruzzese D; Iaccarino A; Troncone G; Veneziani BM; Montuori N; Placido S; Bianco R
Sci Rep; 2017 Aug; 7(1):9388. PubMed ID: 28839232
[TBL] [Abstract] [Full Text] [Related]
10. Urokinase-type plasminogen activator receptor promotes proliferation and invasion with reduced cisplatin sensitivity in malignant mesothelioma.
Wang S; Jiang L; Han Y; Chew SH; Ohara Y; Akatsuka S; Weng L; Kawaguchi K; Fukui T; Sekido Y; Yokoi K; Toyokuni S
Oncotarget; 2016 Oct; 7(43):69565-69578. PubMed ID: 27602956
[TBL] [Abstract] [Full Text] [Related]
11. Suppressive effects of a proton beam on tumor growth and lung metastasis through the inhibition of metastatic gene expression in 4T1 orthotopic breast cancer model.
Kwon YS; Lee KS; Chun SY; Jang TJ; Nam KS
Int J Oncol; 2016 Jul; 49(1):336-42. PubMed ID: 27176787
[TBL] [Abstract] [Full Text] [Related]
12. Methylation of neurofilament light polypeptide promoter is associated with cell invasion and metastasis in NSCLC.
Shen Z; Chen B; Gan X; Hu W; Zhong G; Li H; Xie X; Liu Y; Li H; Xu X; Huang Z; Chen J
Biochem Biophys Res Commun; 2016 Feb; 470(3):627-634. PubMed ID: 26801564
[TBL] [Abstract] [Full Text] [Related]
13. Plasminogen Activator Inhibitor-2 Plays a Leading Prognostic Role among Protease Families in Non-Small Cell lung cancer.
Su CY; Liu YP; Yang CJ; Lin YF; Chiou J; Chi LH; Lee JJ; Wu AT; Lu PJ; Huang MS; Hsiao M
PLoS One; 2015; 10(7):e0133411. PubMed ID: 26230665
[TBL] [Abstract] [Full Text] [Related]
14. Spontaneous lung and lymph node metastasis in transgenic breast cancer is independent of the urokinase receptor upaR.
Almholt K; Lærum OD; Nielsen BS; Lund IK; Lund LR; Rømer J; Jögi A
Clin Exp Metastasis; 2015 Aug; 32(6):543-54. PubMed ID: 26040548
[TBL] [Abstract] [Full Text] [Related]
15. The cystic fibrosis transmembrane conductance regulator as a biomarker in non-small cell lung cancer.
Li J; Zhang JT; Jiang X; Shi X; Shen J; Feng F; Chen J; Liu G; He P; Jiang J; Tsang LL; Wang Y; Rosell R; Jiang L; He J; Chan HC
Int J Oncol; 2015 May; 46(5):2107-15. PubMed ID: 25760446
[TBL] [Abstract] [Full Text] [Related]
16. Downregulation of CFTR promotes epithelial-to-mesenchymal transition and is associated with poor prognosis of breast cancer.
Zhang JT; Jiang XH; Xie C; Cheng H; Da Dong J; Wang Y; Fok KL; Zhang XH; Sun TT; Tsang LL; Chen H; Sun XJ; Chung YW; Cai ZM; Jiang WG; Chan HC
Biochim Biophys Acta; 2013 Dec; 1833(12):2961-2969. PubMed ID: 23916755
[TBL] [Abstract] [Full Text] [Related]
17. [Expression and clinical relevance of upa and ET-1 in non-small cell lung cancer].
Jiang Y; Liu Y; Shi Z; Wang B; Shang L; Xu X; Zhang S; Wang M
Zhongguo Fei Ai Za Zhi; 2011 Jan; 14(1):49-53. PubMed ID: 21219832
[TBL] [Abstract] [Full Text] [Related]
18. Association of polymorphisms in the genes of the urokinase plasminogen activation system with susceptibility to and severity of non-small cell lung cancer.
Shih CM; Kuo WH; Lin CW; Chen W; Cheng WE; Chen SC; Lee YL
Clin Chim Acta; 2011 Jan; 412(1-2):194-8. PubMed ID: 20937265
[TBL] [Abstract] [Full Text] [Related]
19. Isolation and characterization of an inhibitory human monoclonal antibody specific to the urokinase-type plasminogen activator, upa.
Sgier D; Zuberbuehler K; Pfaffen S; Neri D
Protein Eng Des Sel; 2010 Apr; 23(4):261-9. PubMed ID: 20086040
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic significance of urokinase plasminogen activator receptor and its cleaved forms in blood from patients with non-small cell lung cancer.
Almasi CE; Høyer-Hansen G; Christensen IJ; Pappot H
APMIS; 2009 Oct; 117(10):755-61. PubMed ID: 19775344
[TBL] [Abstract] [Full Text] [Related]
[Next]
